Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
DXBRF = DixBarf Boy what a disappointment. A defunct brand name, a miserable equity and zero traction in an explosive market despite being one of the the first cannabis brands.......
There are a number of manufacturers of cannabinoid patches. State and federal regulations present logistical challenges because THC can’t be moved across state lines. Therefore, manufacturers of patches containing THC must have individual operations in each state in which they sell products. Moreover, patches containing THC can be sold only through dispensaries. This leads to questions about consistency and quality of these types of products. Patches that contain only CBD are more readily available and can even be purchased online.
DGTrader, As a note of interest. If one has a Patent Pending issued then the IP is protected against infringement and when the Patent is issued it is legally defendable. Defensible.
Investopedia: "Such a designation (Pat Pend.) serves as a means of notifying the public and other businesses or inventors–notably possible patent or trademark infringers—that they could be held liable for damages once a patent is issued."
So if the thing is Patentable then the IP is golden assuming there is not a work-around, that is, a way to do the same thing in another way which would also be Patentable.
Dixie / Bell Rock / whatever they call themselves Complete trash. This stock is garbage, because the company is garbage. I was initially excited to be investing in this company, having seen and used their products for years. Well, that excitement has faded. I’m only in for what I can easily afford to lose but man, what a disappointment.
Reverse split eminent. Maybe after that there will be signs of life but that’s the only thing I expect this company to make good on since the whole name change and merger have been nothing but unspectacular debacles.
been here since 15' and just about seen it all...i can say without doubt this one takes the cake...if it was your birthday they would want to steal your cake and resell it for few pennies higher...after everything with this companies...some real losers at work here...high level shenanigans...!...slimly crooks similar to ithuf...
Additionally, the BellRock board of directors (the "Board") has approved the consolidation of the common shares (the "Shares") of the Company on a 30 to 1 basis (the "Consolidation"). The Company will now seek necessary regulatory approvals to consummate the Consolidation. The date on which the Shares will begin trading on a post-Consolidation basis will be announced once the necessary approvals have been received.
This stock is a powder keg! Dixie is a significant MJ brand. The company started in CO and has expanded to multiple states over the past few years.
With upcoming legalization I don’t know how DXBRF hasn’t exploded. When the Safe Banking Act and/or More Act pass, Bell Rock will have access to traditional bank loans instead of dilution. THIS WILL BE MASSIVE.
Not that I know of. I’ve seen plenty of modern MJ products; breath strips, liquids concentrates and such but I don’t know if any patches on the market. That sounds like something GW would develop so good on Bell Rock if they got that going
As of now, I dont think any other brands are doing these transdermal patches and wonder if the potential for patent infringement has been a deterrent for other companies to make their own. Please correct me if I'm wrong though. I think Mary's is a diamond waiting to be found.
I posted links to their actual patents in my last post but here is the abstract from their patent pending
Abstract The present invention includes a transdermal patch which contains a pharmaceutically effective amount of a cannabinoid for delivery of the cannabinoid to the bloodstream of a user. The patch may comprise the following components: a backing; and a skin-adhesive polymer matrix attached to one side of the backing, which includes a cannabinoid, a carrier agent, a terpene, and a permeation agent. The cannabinoid is capable of diffusing from the matrix in the transdermal patch into the bloodstream of the user, and may be used in methods for treating a patient suffering from a condition such as pain, nausea and emesis, convulsions, muscle spasm, inflammation, depression, and cachexia.
This shows they have a patent for some form of transdermal delivery - which could be powerful depending on how revolutionary it is. It does not suggest they own an exclusive patent for any and all transdermal patch delivery systems. Big difference. Is there information suggesting the latter? If so, that could indeed be big news.
Widely recognized for its innovative portfolio of delivery methods, Mary's suite of cannabis products includes transdermal gels, patches, and topicals. Founded in 2013, the company possesses a robust library of intellectual property including a U.S. patent for its acclaimed transdermal technology. Dixie, a pioneer in the development of infused cannabis products since 2010, has built a robust stable of products including beverages, gummies, mints, and taffies. Dixie is the #1 edibles brand in the dynamic Michigan market (Source: Leaflink MarketScape, November 2020). Together, the BellRock brands offer one of the largest spectrums of high-quality consumer packaged goods in the cannabis industry with 11 brands and over 200 SKUs.
If true, that’s a potential game changer It’s one thing to be selling retail cannabis goods, something that will only increase as prohibition decreases but to hold a patent on transdermal delivery systems like a patch could be worth billions in licensing alone
Once people catch on to the fact that Mary's holds the patent on Transdermal technology, this is game over.
Advantages of transdermal cannabis patches
Patches have long been used by the pharmaceutical industry to deliver compounds, including nicotine, estrogen, testosterone, the high-blood pressure medication clonidine, and the heart drug nitroglycerine. The mechanism is always the same: the patch is applied to the skin and the drug seeps into the bloodstream.
The direct-to-bloodstream path offers several advantages over other forms of cannabis consumption. For starters, delivery of the active ingredients is slow and steady. “With inhaling,” Riggle said, “you get a high dose right away, which your body metabolizes quickly. There's instant stimulation of the endocannabinoid system [ECS]. With slower, prolonged delivery, you can get the endocannabinoid system to where it's functioning optimally.”
Secondly, patches don't have the toxic byproducts of consumption methods such as smoking or vaping.
Transdermal patches also offer a key benefit over oral methods of consumption — tinctures, edibles, or sublingual sprays, strips, or drops. Consuming cannabis orally is what's known in pharmacology as “first-pass metabolism.” That means the active ingredient passes through your digestive system and then your liver before it reaches its intended destination; in the case of cannabis products, that's the ECS. As a result of that first pass, potency is greatly reduced. “If you orally consume 10 milligrams of THC or CBD, roughly half of that will be metabolized during a first pass,” Riggle said. Transdermal patches sidestep that dilution.
One final advantage: better control. “You can find out what dose works best for you,” Riggle said, “and then get the same precise dose every time
BellRock Brands Executes on Growth Strategy by Expanding into Florida via MedMen Partnership
BellRock Brands Inc. Dec 17, 2020, 06:00 ET
MedMen stores across the state will begin carrying diverse line of Mary's and Dixie products in Q1 2021
DENVER, Dec. 17, 2020 /CNW/ - BellRock Brands Inc. ("BellRock" or "the Company") (CSE: BRCK.U), an industry-leading cannabis consumer packaged goods ("CPG") multi-state operator ("MSO"), announced today that the Company has entered into a licensing agreement with MedMen Enterprises Inc. ("MedMen") (CSE: MMEN) (OTCQX: MMNFF) to bring flagship brands, Mary's and Dixie, into MedMen stores across the state of Florida. MedMen, a leading cannabis retailer with operations across the United States, is now licensed to manufacture, distribute and sell Mary's Medicinals and Dixie products in their Florida retail locations.
Widely recognized for its innovative portfolio of delivery methods, Mary's suite of cannabis products includes transdermal gels, patches, and topicals. Founded in 2013, the company possesses a robust library of intellectual property including a U.S. patent for its acclaimed transdermal technology. Dixie, a pioneer in the development of infused cannabis products since 2010, has built a robust stable of products including beverages, gummies, mints, and taffies. Dixie is the #1 edibles brand in the dynamic Michigan market (Source: Leaflink MarketScape, November 2020). Together, the BellRock brands offer one of the largest spectrums of high-quality CPG products in the cannabis industry with 11 brands and over 200 SKUs.
"Florida represents an important market in our growth strategy, and we are very pleased to team up with MedMen to bring our flagship brands, Mary's and Dixie, into their stores and make our products available to residents in the state," said BellRock Brands Chief Executive Officer, Chuck Smith. "With the Florida market recently embracing infused products, we expect strong growth as the market continues to expand and the demand for diverse cannabis products increases."
BellRock expects to launch its initial products, including topicals, transdermal patches and gels, and ingestibles in Florida with MedMen during the first quarter of 2021, pending regulatory approval, with the balance of the portfolio coming on-line throughout the remainder of the year. The Company expects to begin distribution during Q1 across the entire MedMen retail platform, which includes four operational stores with plans to open in Miami Beach early in 2021.
"We are thrilled to have BellRock Brands join our product offering in Florida," said Tom Lynch, MedMen Interim Chief Executive Officer and Chairman of the Board. "Mary's and Dixie are two brands we hold in high regard, not only for their longstanding heritage in the cannabis industry, but also their focus on creating quality, trustworthy products that appeal to a wide range of cannabis consumers."
The Road to a Billion Dollar Brand Over the past few year Canadian MJ stocks have soared from pennies to dollars. There are 2 scenarios for which I see this happening for DXBRF
1. Dems win the GA Senate seats and the MORE Act is voted into law.
2. Biden decriminalizes via Executive Order
Both scenarios remove cannabis from the absurd Schedule 1 status, thus paving the way for banks to loan money to US MJ companies. THIS WILL OPEN THE FLOOD GATES. These companies will no longer rely on dilution and can have access to traditional loans, payroll write-offs and the other financial instruments available to “legal” entities
BellRock Brands Strengthens Presence in Nevada via Exclusive Licensing Agreement with Matrix NV
DENVER, Dec. 8, 2020 /CNW/ - BellRock Brands Inc. ("BellRock" or "the Company") (CSE: BRCK.U), an industry-leading cannabis consumer packaged goods ("CPG") multi-state operator ("MSO"), announced today that the Company has entered into a licensing agreement with Matrix NV, LLC (Matrix NV) to unify its award-winning Mary's and Dixie brands under one production and distribution partner in Nevada. Matrix NV, a Las Vegas, NV-based cannabis flower, concentrate and infused products producer, is now licensed to manufacture, distribute, and sell Mary's Medicinals and Dixie products to all cannabis retailers in the state. Those products include Mary's Medicinals Transdermal patches, Mary's Medicinals Transdermal gels, Mary's Medicinals Transdermal/topical compounds, Dixie gummies, Dixie mints and Dixie Elixirs.
Widely recognized for its innovative portfolio of delivery methods, Mary's suite of cannabis products includes transdermal gels, patches, and topicals. Founded in 2013, the company possesses a robust library of intellectual property including a U.S. patent for its acclaimed transdermal technology. Dixie, a pioneer in the development of infused cannabis products since 2010, has built a robust stable of products including beverages, gummies, mints, and taffies. Dixie is the #1 edibles brand in the dynamic Michigan market (Source: Leaflink MarketScape, November 2020). Together, the BellRock brands offer one of the largest spectrums of high-quality consumer packaged goods in the cannabis industry with 11 brands and over 200 SKUs.
"We are very pleased to partner with Matrix in Nevada and expand the presence of both Mary's and Dixie in the state," said Chuck Smith, Chief Executive Officer of BellRock. "This strategic partnership provides us with the opportunity to leverage our previous experience and operations in Nevada and bring a broader, more robust portfolio of BellRock products to this compelling market. As an experienced operator with a proven track record, Matrix is the perfect partner to help us introduce our iconic brands to more customers across the country and continue achieving our goal of building the first national cannabis brand."
BellRock expects to launch products in Nevada with Matrix NV during the first quarter of 2021. Retail sales of THC products across the state are estimated to exceed $780 million according to BDS Analytics.
"We have long admired both Mary's and Dixie for their commitment to providing cannabis consumers with quality, trustworthy products and their unique delivery methods. Their focus on producing a wide variety of superior products mirrors ours," said David Tuttleman, Chief Executive Officer of Matrix NV. "Adding these two established brands to our product portfolio is an exciting next step and we look forward to broadening their presence in Nevada and tapping the potential of the cannabis market in this state."
I’m surprised to see this trading so thin With so many other penny pot plays going up, most of which are total scams, I surprise DXBRF, which has several legit cannabis brand, is trading so thin
DENVER, Colo., Dec. 2, 2020 /CNW/ - BellRock Brands Inc. ("BellRock" or "the Company") (CSE:BRCK.U), an industry-leading cannabis consumer packaged goods ("CPG") multi-state operator("MSO"), announced Q3 2020 financial results for two of its anchor brands, MM Technology Holdings, LLC ("Mary's") and Dixie Brands Inc. ("Dixie"). All figures are stated in U.S. dollars. Mary's and Dixie posted their Q3 financial statements on SEDAR on November 30th in compliance with the Canadian Securities Exchange regulatory requirements. The statements reflect the financial results for the merged companies prior to the closing of the merger that created BellRock. Please note, that the following results are only for the Mary's and Dixie assets and exclude all other brands currently in the BellRock ecosystem. "The third quarter of 2020 proved to be pivotal in laying the foundation of the BellRock Brands platform, which has emerged from the transaction as the cannabis industry's preeminent CPG platform," said Chuck Smith, CEO of BellRock Brands and formerly President and CEO of DixieBrands. "While the transaction wasn't formally closed until October 31st, the respective teams [as BR Brands and Dixie Brands] worked relentlessly throughout Q3 to advance major integration milestones alongside of marching the merger to completion. This material progress paves the way for the merged company to hit the ground running, all while demonstrating continued robust commercial growth in a COVID impacted marketplace."
Q3 Financial Highlights
Mary's - Total Revenue derived from sales of Mary's branded products for the nine months ended September 30, 2020 was $19,313,989, an increase of $2,115,729 (+12%) over the same period in 2019. Growth experienced in the nine months ended September 30, 2020 vs. prior year was driven by multiple factors: (i) expansion into the evolving Oklahoma market (ii) accelerating growth in the California market, and (iii) legalization of adult use marijuana in Michigan. Gross profit for the nine months ended September 30, 2020 was $9,221,556, an increase of$5,774,868 (+67%) over the same period in 2019. Net Income attributed to Mary's in Q3 2020 was $1,419,870 compared to the Q3 2019 loss of$2,948,121, a 148% improvement directly related to a focus on cost containment and margin improvement. Removing the non-cash related expenses, the adjusted net gain before non-controlling interest for Q3 2020 was $2,480,639.
Dixie - Licensing revenue derived from affiliate sales of Dixie branded products in their related states for the three months ended September 30, 2020 was $4,275,129, an increase of $1,382,234(+48%) from the third quarter of the prior year. For the nine months ended September 30, 2020licensing revenue was $11,216,191, an increase of $3,850,154 (+52%) from the prior year. Total revenue for the nine months ended September 30, 2020 was $11,596,034, an increase of $3,261,338 (+39%) vs prior year. Growth experienced in the three months ended September 30, 2020 vs. prior year was predominantly driven by continued revenue growth and increasing market penetration across existing key markets, such as California (+21%), Colorado (+20%), Maryland (+68%), and Michigan (+595%). Gross profit for the three months ended September 30, 2020 and 2019 was $1,851,074 and$1,344,043, respectively, an increase of $507,031 (+38%). Gross profit for the nine months ended September 30, 2020 was $4,562,794, an increase of $1,118,320 (+33%) over the same period in 2019. Net loss attributed to the Company in Q3 2020 was $2,749,893 compared to the Q3 2019 loss of $4,915,807, a 44% improvement directly related to the impact of the company's 'Path to Profitability' strategy implemented in Q3 2019. Removing the non-cash related expenses and interest expenses that are expected to be converted to equity in the proposed transaction, the adjusted net gain before non-controlling interest for Q3 2020 was $504,792. Q3 Operating Highlights
Mary's - Grew California revenue 13% year-over-year in Q3 through an expanded self-distribution network and increased dispensary penetration. Recognized as the #2 topicals and tinctures company in Colorado (Source: BDS Analytics, November 2020) Increased license revenue in Michigan +35% year-over-year in Q3, as a result of increasing consumer demand for Mary's products in the medical and adult-use markets. Entry into Oklahoma generated an additional $915K of revenue year over year. Q3 optimization efforts in production and operating expenses led to overall SG&A reductions of$1.7M.
Dixie - Received overwhelming shareholder approval at the July 14th Annual General and Special meeting for the merger with BR Brands, bringing together two highly recognized portfolios including the iconic Mary's and Dixie brands, creating an industry-leading CPG MSO. Grew Colorado licensing revenue by 20% in Q3 2020 compared to 2019 through a continued increase in organic consumer demand, demonstrating strong brand health in a mature market. Dixie is the #2 edibles company in Colorado's recreational cannabis market (Source: BDS Analytics November 2020) Increased license revenue in California year-over-year by 55% in the nine months ended September 30, 2020 via increased dispensary penetration, enhanced brand awareness and increased consumer-driven sales velocity. Dixie's award-winning gummies saw growth in excess of 90% vs the same period in 2019. Grew Maryland license revenue by 68% year-over-year in Q3, as a result of increasing consumer demand for an established CPG portfolio with stable market penetration.
Consumer demand continued to exceed expectations in Michigan resulting in a 595% year-over-year increase in license revenue for Q3. Dixie is the #1 edibles brand in the dynamic Michigan market. (Source: Leaflink Market Scape, November 2020)."Despite the headwinds and common challenges of 2020, I am incredibly proud of the results that the collective BellRock team managed to achieve," said Chuck Smith, CEO BellRock Brands."Combined, BellRock has delivered over $30M in revenue through the end of September 2020.Continued top line growth combined with comprehensive cost management has secured the foundation of the BellRock Brands platform to drive continued growth as the industry's preeminent CPG house of brands.
"Outlook – BellRock Brands On July 14, 2020, the proposed merger between BR Brands and Dixie Brands was overwhelmingly approved by Dixie shareholders and the transaction was completed on October 31, 2020. Under the terms of the deal, BR Brands combined operations with Dixie assuming the publicly traded platform via a reverse takeover. This transaction has strengthened the balance sheet of the combined entity and is expected to drive upside potential through synergies, as well as operational efficiencies, providing long-term, stable growth for shareholders and a best-in-class product portfolio for consumers across the globe. The combined company establishes one of the cannabis industry's most comprehensive 'house of brands' anchored by two of the most iconic consumer franchises in the market, Mary's and Dixie.The portfolio also boasts Rebel Coast and Defonce (two emerging Californian brands), a deep CBD program including the Mary's CBD, Aceso and Therabis brands, and the strategic partnership with Herbal Enterprises, LLC, an affiliate of the AriZona brand. An unrivaled leadership team with deepCPG, financial and capital markets experience will guide one of the largest installed manufacturing and distribution footprints for infused products in the cannabis industry. With 11 brands and over 200SKUs, BellRock reaches nearly every key consumer group and addresses the needs of a diverse cannabis consumer base. BellRock remains committed to growing shareholder value. The company's buy-and-build growth strategy employs a three-pronged approach to enhancing its platform through strategic acquisitions, prioritizing profitable organic revenue growth, and continuously optimizing its costs and capital structure. On a pro forma basis, assuming BR Brands and Dixie had combined as of January 1,2020, BellRock expects to generate in excess of $40 million in revenue in 2020, with clear plans to deliver exponential revenue and cash flow growth in 2021 and beyond.
Both Dixie and Mary's filed its complete Q3 2020 financial statements and management discussion and analysis at www.sedar.com.
ABOUT BELLROCK BRANDS: BellRock Brands, is a brand and IP focused CPG, multi-state operator, possessing one of the industry's broadest branded product portfolios catering to the growing and ever-evolving cannabis consumer. BellRock's portfolio consists of two iconic cannabis brands with deep history, Mary's Brands (a pioneer in the Health & Wellness segment since 2013) and Dixie (a market leading THC infused edibles brand since 2010), as well as two growing, California-based brands, Rebel Coast and Défoncé. Together, the BellRock brands offer a vast spectrum of high-quality cannabis-centric consumer packaged goods. With 11 brands and over 200 SKUs, BellRock reaches nearly every key consumer group and addresses the needs of a diverse cannabis consumer base. The BellRock manufacturing and distribution footprint continues to expand and currently spans nine states, and the Company owns or manages production facilities in its largest markets.
For more information, visit www.bellrockbrands.com.
For more information please contact info@BellRockBrands.com
What is with the broken charts here on ihub? Are they having issues of just messing with us? It is not just here, there are many stocks that are ready to soar and the charts here do not give a price or volume
Rebranding won’t be easy. They have the multi-state supply chain but loose the brand recognition. Oddly enough the company still posts on IG under the Dixie label. Previously I did not associate Dixie negatively but better to disconnect from the name sooner than later.
The only thing I see as a possible hurdle is the renaming of dixie products. Recognition will not happen unless they do a big campaign to inform consumers
This is a nationally recognized cannabis brand. They have the licensing, the distribution, the name recognition and over a decade of market experience.
By all means this could and should easily become a billion dollar brand. Once the USA reschedules cannabis, the company can get funding from banks and institutions.
The lack of access to institutional monies is really the only thing holding this industry back. Once that logjam is remove, the money flow will pour in.
Hopefully when they release the combined financials for the two companies combined with the DEM taking over US in 2021 should start pushing this upward.
I feel better now that if I want I can trade them finally. I am going to stay here and see which way it turns. I like the way they used the down time to rebrand, that shows me they have an interest in having a real business. I am glad they are with other brands I have heard of, I will give them time to show their plan forward
My brokerage is screwy, the chart shows .15 as the price and the ask at .30 meanwhile on my account page it shows the current value at .06 seems there is some confusion lol!
My brokerage is screwy, the chart shows .15 as the price and the ask at .30 meanwhile on my account page it shows the current value at .06 seems there is some confusion lol!
ETurd shows the DXBRF symbol but under the name Bellrock Brands (used to be Dixie). The share price was at .14, now showing .15 with 19000 shares traded?
I tried to enter an order for 15000 shares at .15 but it has not filled.
News 
Market Data 
Discover 
